KALA BIO, Inc. — Form 8-K
Filed August 28, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
KALA BIO filed Form 8-K on 2026-08-28 reporting Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, with transfer of listing mentioned. No specific dollar amounts, counterparties, or remediation details are disclosed in the header/metadata provided. The filing indicates the company has violated exchange continued listing requirements.
Why this rating
Delisting is existential for a $24.6M public company; loss of exchange listing destroys shareholder value, liquidity, and market access. Business-altering event.
Extracted items
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.